Active not recruiting × INDUSTRY × Observational × Clear all MiDura
Active not recruiting
328 enrolled
ACROBAT
Active not recruiting
307 enrolled
NIS durvalumab
Active not recruiting
250 enrolled
ACT-MBC
Active not recruiting
65 enrolled
RosaLEE
Active not recruiting
1,019 enrolled
MG Cohort
Active not recruiting
1,199 enrolled
OPAL
Active not recruiting
537 enrolled
ArtemisPRO
Active not recruiting
504 enrolled
Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions
Active not recruiting
1,178 enrolled
VICTORIE
Active not recruiting
1 enrolled
PASS of Paediatric Patients Initiating Selumetinib
Active not recruiting
124 enrolled
PICAROS
Active not recruiting
192 enrolled
Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
Active not recruiting
44 enrolled
JPMS-DTC
Active not recruiting
453 enrolled
NAOS
Active not recruiting
350 enrolled
CABOCARE
Active not recruiting
224 enrolled
REPLICA
Active not recruiting
150 enrolled
Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations
Active not recruiting
1,500 enrolled
DAROL
Active not recruiting
805 enrolled
ARSENAL
Active not recruiting
254 enrolled
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Active not recruiting
360 enrolled
PARFENOPA
Active not recruiting
329 enrolled
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Active not recruiting
400 enrolled
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection
Active not recruiting
78 enrolled
Brilliant
Active not recruiting
154 enrolled
SH-SOC23
Active not recruiting
132 enrolled
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
Active not recruiting
2,907 enrolled
CREATE
Active not recruiting
712 enrolled
REACH
Active not recruiting
250 enrolled
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.
Active not recruiting
35 enrolled
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
Active not recruiting
60 enrolled
Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants
Active not recruiting
84 enrolled
MUST
Active not recruiting
250 enrolled
AB1MALT
Active not recruiting
35 enrolled
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
Active not recruiting
1,000 enrolled
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
Active not recruiting
1,200 enrolled
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
Active not recruiting
1,000 enrolled
ARISE
Active not recruiting
151 enrolled
Tumor-induced Osteomalacia Disease Monitoring Program
Active not recruiting
23 enrolled
DADOX
Active not recruiting
100 enrolled
SEATTLE
Active not recruiting
75 enrolled
SHIELD
Active not recruiting
12,000 enrolled
MRD
Active not recruiting
1,017 enrolled
IMreal
Active not recruiting
2,756 enrolled
A Study of NINLARO® in Chinese Adults With Multiple Myeloma
Active not recruiting
72 enrolled
FOREFRONT
Active not recruiting
532 enrolled
Evaluating Bladder CAREâ„¢, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
Active not recruiting
80 enrolled
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan
Active not recruiting
145 enrolled
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Active not recruiting
354 enrolled
An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal Cancer
Active not recruiting
787 enrolled